As part of these responses, changes in expression of CSE, CBS, and MST in the AMPs, BMPs, and human endothelial cells may contribute to the pathophysiology of MS and potentially other neurovascular conditions. This evidence concerns the gene CLN5 and myeloid sarcoma.